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This review discusses hemoglobin D-Punjab, also known as hemoglobin D-Los Angeles, one
of  the most common hemoglobin variants worldwide. It is derived from a point mutation
in  the beta-globin gene (HBB: c.364G>C; rs33946267) prevalent in the Punjab region, North-
western Indian. Hemoglobin D-Punjab can be inherited in heterozygosis with hemoglobin
A  causing no clinical or hematological alterations, or in homozygosis, the rarest form of
inheritance, a condition that is commonly not related to clinical symptomatology. Moreover,
this  variant can exist in association with other hemoglobinopathies, such as thalassemias;
the  most noticeable clinical alterations occur when hemoglobin D-Punjab is associated to
hemoglobin S. The clinical manifestations of this association can be similar to homozygo-
sis for hemoglobin S. Although hemoglobin D-Punjab is a common variant globally with
clinical importance especially in cases of double heterozygosis, hemoglobin S/D-Punjab is
still  understudied. In Brazil, for example, hemoglobin D-Punjab is the third most common
hemoglobin variant. Thus, this paper summarizes information about the origin, geographic
distribution, characterization and occurrence of hemoglobin D-Punjab haplotypes to try
to  improve our knowledge of this variant. Moreover, a list of the main techniques used
in  its identiﬁcation is provided emphasizing the importance of complementary molecular
analysis for accurate diagnosis.©  2015 Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published
by Elsevier Editora Ltda. All rights reserved.
thalassemia, or they can modify molecule structure and gen-
1,2IntroductionMutations in genes encoding hemoglobin chains are present in
about 7% of worldwide population.1 These genetic alterations
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erate hemoglobin variants.
Hemoglobin variants usually are the consequence of sin-
gle amino acid substitutions caused by point mutations
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Figure 1 – Restriction polymorphic sites in cluster
beta-globin for haplotypes screening in association with Hb
D-Punjab
19rev bras hematol hemot
n genes encoding globin chains, resulting in a tetramer
ith different physicochemical characteristics.3 According to
he Globin Gene Server database (http://globin.cse.psu.edu/),
198 hemoglobin variants were described until Septem-
er 2014. Most of the hemoglobin variants described do
ot cause symptomatic clinical manifestations; however, in
ome cases, they can be associated to relevant pathophysi-
logy, e.g., hemoglobin S (Hb S). Hb S is the most frequent
emoglobin variant in the world; its clinical outcome is severe
n homozygous or in association with other relatively com-
on  hemoglobinopathies, such as beta-thalassemia, Hb C or
b D.3,4 Different to the other hemoglobinopathies, this last
ne is still poorly studied, especially in Brazil, where there are
ew recent studies about its prevalence, diagnosis and clini-
al aspects. Moreover, Hb D presents considerable geographic
istribution and can be associated with Hb S, forming a het-
rozygous composite with peculiar clinical severity.
Thus, this study aimed to gather information available in
he literature about type D hemoglobins, more  speciﬁcally
bout Hb D-Punjab, in order to draw attention to its impor-
ance and to encourage the scientiﬁc community to take
nterest in the subject, particularly in Brazil where studies on
his variant are scarce.
istory
ntil the early 1950s, only four types of hemoglobin had been
escribed including adult hemoglobin (Hb A) and two variants
Hb S and Hb C). The fourth identiﬁed hemoglobin was Hb D
hich was ﬁrst described by Itano in 1951. In his study, Itano
as analyzing a multiethnic family from the Los-Angeles
egion with British, American and Indian features, and found
 molecule with characteristics different to the other known
emoglobins. This hemoglobin had electrophoretic mobility
imilar to Hb S in alkaline pH, however, in acid pH, its migra-
ion resembled Hb A. Furthermore, Hb D exhibited normal
olubility when in its reduced state and did not undergo
ickling.5,6
Since the discovery of this new variant and the knowledge
f its molecular structure, other hemoglobins with similar pat-
erns discovered in populations from different ethnicities have
een nominated according to the regions in which they were
escribed. In a study performed in 1962, Baglioni analyzed the
olecular structure of ﬁve hemoglobins, Hb D-Chicago, Hb D-
orth Carolina, Hb D-Punjab, Hb D-Portugal and Hb D-Oak
idge and found that all exhibited the same chemical com-
osition as the ﬁrst one discovered, Hb D-Los Angeles.6,7 The
ost frequent denominations for this mutant hemoglobin
ound in the literature are Hb D-Los Angeles or Hb D-Punjab.
utation  ˇ121  Glu→Gln  (GAA→CAA)
b D-Punjab is a variant derived from a point muta-
ion in the beta-globin gene (HBB) in the ﬁrst base of
he 121 codon (GAA→CAA) with the substitution of glu-
amine for glutamic acid (Glu>Gln) in the beta globin chain.8ccording to the Globin Gene Server database, besides Hb
-Punjab, there are seven other types of Hb D, caused
y different point mutations in HBB. They are Hb D-
gri (HBB:c.29C>A;364G>C), Hb D-Bushman (HBB:c.49G>C),Source: Modiﬁed from Yavarian et al.
Hb D-Ouled Rabah (HBB:c.60C>A or 60C>G), Hb D-Iran
(HBB:c.67G>C), Hb D-Granada (HBB:c.68A>T), Hb D-Ibadan
(HBB:c.263C>A) and Hb D-Neath (HBB:c.365A>C).
Origin  and  geographic  distribution
Hb D-Punjab is one of the most common hemoglobin variants
worldwide, after Hb S and Hb C. It is prevalent in Punjab region,
Northwest Indian, with an estimated frequency of 2.0%. In
western India, more  speciﬁcally in the Gujarat region, its fre-
quency drops by one half.9
Hb D-Punjab is also common in countries such as Italy,10
Belgium,11 Austria12 and Turkey.13 Hb D-Punjab is the second
most common hemoglobin alteration in Turkey; it occurs in
0.2% of the population of Denizli province in southeastern
Turkey, where it is the most common variant. A total of 57.9%
of abnormal hemoglobins observed in this province are Hb D-
Punjab, followed by Hb S, with 21.9%.13 A similar frequency
occurs in Xinjiang province, northwestern China, where 55.6%
of variant hemoglobins are Hb D-Punjab.14,15
In Brazil there are no recent studies reporting the fre-
quency of Hb D-Punjab in the population, but in a large survey
conducted in 1993 by Bonini-Domingos, which evaluated the
prevalence of hemoglobinopathies in about 100,000 Brazil-
ian individuals from every state in the country, Hb D-Punjab
was observed to be the third most common hemoglobin
variant in the population.16 Posteriorly, in a screening for
hemoglobinopathies performed in a hospital-based popula-
tion in southeastern Brazil by Sonati et al., the authors found
hemoglobin alterations in 34.4% of the individuals, of which
0.4% corresponded to Hb D-Punjab. Despite the low frequency,
Hb D-Punjab was also the third most frequent variant identi-
ﬁed in this population.17
Initially, the geographic distribution of Hb  D-Punjab sug-
gests that this mutation originated in the central region of
Asia, as it is prevalent in Punjab, a region of India, and
Northwestern China. Then it spread to neighboring countries
by migration.11,18,19 However, haplotype analysis of beta-
globin clusters provides another insight into the origin of this
hemoglobin. The analysis of polymorphic sites, 5′- HincII, G
HindIII, A HindIII,  HincII, 3′- HincII, 5′- HinfI,  AvaII, 3′-
HinfI, 3′- BamHI (Figure 1), showed certain haplotypes associ-
ated to Hb D-Punjab, suggesting a multicentric origin for this
mutation.19–24The study of Atalay et al. considered seven beta-globin
gene polymorphic sites (5′- HincII, G HindIII, A HindIII, 
HincII, 3′- HincII,  AvaII and 3′- HinfI) and identiﬁed three
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Table 1 – Haplotypes described in the literature associated with Hb D-Punjab and the locations where they were  ﬁrst
found.
Polymorphic sites of cluster beta Occurrence
5′-
HincII
G
HindIII
A
HindIII

HincII
3′-
HincII
5′-
HinfI

AvaII
3′-
HinfI
3′-
BamHI
+ − − − − NR + NR + Mexico,18,20 Italy,10,18
Iran18,21
+ − − − − NR + + NR Turkey,18,22 India19
− + + − + NR + NR + Thailand8,18
− + + − + NR + + NR Turkey18
− + − − + NR + + NR Turkey18
− − + − + NR + + NR Turkey22
+ − − − − + NR + NR Iran, the Netherlands,
Belgium17
+ − − − − − NR + NR Iran17
− + − − + + NR + NR Iran17
− + − + + + NR + NR Iran, India, England17NR: not reported.
haplotypes. One of them is the Mediterranean Haplotype I
(+ − − − − + +) which is the most common and found in popu-
lations of Mexico,22 Italy10 and Iran.23 A second recently
discovered pattern was associated to Hb D-Punjab cases in
Thailand (− + + − + + +)8 and the third haplotype was found in
Turkish populations (− + − − + + +).20
In 2009, Yavarian et al. analyzed seven polymorphic sites
(5′- HincII, G HindIII, A HindIII,  HincII, 3′- HincII, 5′- HinfI
and 3′- HinfI) and found four haplotype patterns associated
to Hb D-Punjab in the Indian population. The ﬁrst and most
common was the Mediterranean Haplotype I (+ − − − − + +),
the second seems to be a product of the Mediterranean Hap-
lotype I variation probably due to an independent mutation
(+ − − − − − +), the third was the same haplotype found in
Turkey (− + − − + + +), and the fourth a common haplotype in
Indian and English populations (− + − + + + +).19
Considering the same restriction sites assessed by Ata-
lay et al. in 2007 and in 2009, Bahadir et al. reported the
occurrence of another haplotype in the Turkish population
(− − + − + + +).20,24 Due to lack of studies in Chinese and
Indian populations, Patel et al. evaluated individuals with Hb
D-Punjab from Agharia in India and found another haplo-
type (− − − − − + +) in addition to haplotype I (+ − − − − + +).21
Table 1 summarizes all these results.
As the haplotypes described in association with Hb D-
Punjab are prevalent in different regions, it is suggested that
the origin of the mutation in codon 121 may be multicen-
tric. According to Yavarian et al., one important aspect is that
the mutation site is located in a short palindromic region,
where many  mutations are described, suggesting that codon
121 exhibits a higher mutation rate than is expected. Thus,
there is a chance that mutational events give rise to the
same hemoglobin in different regions.19 However, it is not
yet possible to conﬁrm the origin and distribution of this
hemoglobin as there are few studies about haplotypes in popu-
20lations from China and from other continents such as North,
South and Central America and Africa. In Brazil, no study
has been performed to screen haplotypes associated to Hb
D-Punjab.Inheritance  of  Hb  D-Punjab  and  associated  clinical
features
The Hb D-Punjab can be inherited in heterozygosis with
normal Hb A, characterizing the heterozygous trait. This con-
dition presents no clinical or hematological alterations. The
homozygous component Hb DD, the rarest form of inheri-
tance, is not commonly related to symptomatic cases, but
occasionally individuals with this proﬁle can develop mild to
moderate hemolytic anemia.25,26
The association of this variant with other abnormal
hemoglobins, such as Hb S or thalassemia can also occur. Usu-
ally, interactions between Hb D-Punjab and beta thalassemia
course with mild microcytic and hypochromic anemia, but do
not present relevant clinical or hematological changes.27
However, when Hb D-Punjab is associated to Hb S, the
double heterozygous Hb S/D, the result is moderate to severe
clinical manifestations; this association can be clinically simi-
lar to homozygous Hb SS.25 Pain, due to vaso-occlusive events,
is one of the most common complications. Furthermore,
stroke and acute chest syndrome can occur in carriers of this
genotype.28–30
Recently, Patel et al. published a study on Hb S/D-Punjab
patients with moderate to severe clinical symptomatology
similar to the Hb SS genotype who had vaso-occlusion
episodes or required blood transfusions. The authors observed
greater vulnerability for red cell lysis in Hb S/D-Punjab patients
than with the Hb SS genotype.31 Clinical severity in Hb S/D-
Punjab individuals could be related to the fact that Hb D favors
polymerization of Hb S.32
Polymerization of Hb S molecules is triggered by hydropho-
bic interactions between the Val-6 amino acid of an Hb
S molecule and the Phe-85 and Leu-88 amino acids
of adjacent hemoglobin molecules. Subsequently, these
hydrophobically associated Hb S molecules interact with other
contact sites of Hb S polymers, such as 73 and 121, result-
ing in the formation of a complex polymer structure. Thus,
mutations in these contact sites can affect the biochemical
properties of the Hb S polymers formed. It is believed that
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Figure 2 – Electrophoretic mobility of Hb D-Punjab compared to other known hemoglobins, such as Hb A, S and C. Images
correspond to hemoglobin electrophoresis in cellulose acetate (A), hemoglobin electrophoresis in agarose gel (B),
polypeptide chains electrophoresis in cellulose acetate (C) and polypeptide chains electrophoresis in polyacrylamide gel (D).
The genotypes of each sample are at the top of the ﬁgure. Current direction and position of the different hemoglobins are
beside each method.
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requires speciﬁc kits and is more  expensive than conventional
electrophoresis.
Hb A
Hb F
Hb D-Ouled rabah
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Hb Che amino acid changes in the 121 Glu→Gln position encour-
ge the interaction of Hb S molecules and consequently its
olymerization.33,34 Adachi et al. showed that the Hb S poly-
erization rate is higher when Hb D-Punjab is present. This
ay explain the clinical severity of sickle cell disease in dou-
le heterozygous Hb S/D-Punjab, as Hb D-Punjab increases the
robability of sickling due to a shorter transit time of these
ells in the blood capillaries.32
Hydroxyurea (HU) administration is a potential therapeu-
ic strategy for sickle cell anemia (Hb SS), showing efﬁcacy in
ncreasing Hb F levels and consequently reducing the number
f painful crises, acute chest syndrome, transfusions, and hos-
italizations. However, HU therapy for Hb S/D-Punjab has not
een established. Patel et al. treated Hb S/D-Punjab patients
sing low doses (10 mg/kg/day) of HU noticed an effective
eduction in the incidence of vaso-occlusion and the fre-
uency of blood transfusions. These results suggest that HU
s a promising therapy for clinical symptomatology in Hb S/D-
unjab individuals.31
aboratory  diagnosis
umerous laboratory methods are used to diagnose
emoglobin variants and thalassemias.
Hemoglobins can be separated by electrophoresis in cel-
ulose acetate at pH 8.635 and in agarose gel at pH 6.2.36 In
ellulose acetate, the migration of Hb D is slower than Hb A
ith a position similar to Hb S, but in acid pH its migration
osition is the same as Hb A. These electrophoretic patterns,
owever, are not speciﬁc for variants of the Hb D group, as
here are other hemoglobin variants with similar behavior,
uch as Hb G and Hb Korle-bu.
The structural characterization of hemoglobin variants by
lectrophoretic separation of hemoglobin polypeptide chains
s used in cases in which the results of the initial tests are
nconclusive.37,38 The mutant D chain migrates similar to the
S chain using this method, but slightly below this fractionin alkaline pH, while it migrates to the same position as the
normal A chain in acid pH (Figure 2).
It is also possible to separate hemoglobins according to
their isoelectric point (pI) by isoelectric focusing (IEF).39 In
the case of Hb D-Punjab, its pI is near to pH 7.1, a position
similar to other hemoglobin variants such as Hb Korle-Bu
(Figure 3). Although it has great resolution, this techniqueFigure 3 – Schematic representation of relative mobilities of
different hemoglobins using the isoelectric focusing
method. Hb D-Punjab is shown in the ﬁgure with isoelectric
point (pI) between 7.1 and 7.2.
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Figure 4 – Chromatographic proﬁle of a heterozygous trait for Hb D-Punjab (B and C) and a double heterozygous Hb S/D-Los
Angeles A and D). (A and B) The VARIANT I system chromatogram with heterozygous beta-thalassemia analysis kit. The
arrow indicates the pike corresponding to Hb D-Los Angeles with average retention time of 4.1–4.3 min. It is possible to note
decreases in Hb A2 values, a characteristic of samples with this hemoglobin variant. (C and D) The ultra2 Resolution system
chromatogram with Genesys analysis kit. The arrow indicates the Hb D-Punjab spike, with retention time between 0.92 and
0.96 min  related to Hb S.
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Figure 5 – Agarose gel visualization of fragments generated
by the PCR-RFLP technique for screening of 121 Glu→Gln
(GAA→CAA) mutation. Normal alleles generate two
fragments and mutant alleles maintain the 564 bp
fragment, indicated by the arrows. N: absent mutation;
HET: heterozygous for Hb D-Los Angeles; mm:  molecular
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1arker of 100 bp. Restriction enzyme: EcoRI (G↓AATTC).
High performance liquid chromatography (HPLC) meth-
ds have been developed for hemoglobin fractionation with
igh sensitivity and speciﬁcity. This technique is an inte-
rated method based on ion-exchange to separate and identify
he relative percentage of speciﬁc hemoglobins in whole
lood samples (Figure 4). Another method employed to detect
emoglobin fractions is capillary electrophoresis (CE) based on
he principle of electrokinetic separation. Despite the excel-
ent resolution and reproducibility, this technique is only now
rriving in some countries, including Brazil.
Reverse-phase HPLC (RP-HPLC) of human globin chains
as been reported as an important tool for detecting
emoglobinopathies. Nevertheless, although it is widely
sed for the detection, quantiﬁcation and puriﬁcation of
any proteins from biological materials, its clinical appli-
ation for hemoglobins is still limited due to the long
nalytical time, complex sample preparation and resolution
roblems.40,41 Recently, studies have had success in optimi-
ing the method,40,41 but in many  laboratories the technique
s still employed exclusively for research.
Although all these tests aim to diagnose Hb D-Punjab, they
re not considered conclusive because of the large number
f hemoglobin variants that are similar to each other. It is
lways recommended to perform molecular analysis for geno-
ype conﬁrmation with PCR-RFLP as an alternative42 (Figure 5).
When the Hb D variant is not identiﬁed by the above-
entioned methodologies, sequencing of beta-globin gene or
ther techniques that discriminate amino acid changes are
ecommended.
Using these methodologies over the last 10 years, 70 cases
f type D hemoglobins from southeast Brazil were diag-
osed in the Hemoglobin and Hematological Genetic Diseases
aboratory of the Universidade Estadual Paulista (UNESP) a
eferral center for hemoglobin diagnosis. Of these, 66 (94.3%)
ad a proﬁle compatible to Hb D-Punjab, eight (12.1%) were
ompound heterozygous Hb S/D-Punjab and 58 (87.9%) het-
rozygous Hb A/D-Punjab, all of which were conﬁrmed by
olecular tests. The other four remaining cases presentedlectrophoretic and chromatographic proﬁles compatible with
he “Hb A/D-non-Los Angeles” trait, possibly Hb A/D-Iran (data
ot published).
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Conclusion
Although not always associated with relevant clinical history,
Hb D-Punjab is a relatively common hemoglobin worldwide;
it is the third most common hemoglobin variant in Brazil.
Greater attention is given when the association of Hb D-Punjab
with another abnormal hemoglobin or thalassemia leads to
clinical symptoms. However, this issue is still understudied
especially in Brazil and the pathophysiological mechanisms
caused by Hb D-Punjab are poorly known. There is no recent
information about the prevalence of Hb D-Punjab, association
with other hemoglobin variants, or characterization of typ-
ical haplotypes in the Brazilian population. Therefore, it is
important to conduct studies about this hemoglobin variant.
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